Back
Day Range
$368.44
$375.97
52-Week Range
$368.44
$623.61
Volume
349,724
50D / 200D Avg
$435.41
/
$451.32
Prev Close
$373.89
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 19.9 | 0.2 |
| P/B | 5.4 | 3.0 |
| ROE % | 25.3 | 3.6 |
| Net Margin % | 10.5 | 3.8 |
| Rev Growth 5Y % | 4.3 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$475.00
+27.0%
Forward P/E
15.67
Forward EPS
$23.88
EPS Growth (est.)
+0.0%
Est. Revenue
2.67B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$28.90
$28.76 – $29.06
|
3.00B | 1 |
| FY2027 |
$26.62
$26.07 – $27.17
|
2.83B | 2 |
| FY2026 |
$23.88
$23.77 – $23.97
|
2.67B | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | $7.03 | $6.42 | -8.7% |
| 2025-10-28 | $5.39 | $5.27 | -2.2% |
| 2025-07-29 | $4.78 | $4.27 | -10.7% |
| 2025-04-23 | $5.55 | $5.63 | +1.4% |
| 2025-02-26 | $6.78 | $6.83 | +0.7% |
| 2024-10-29 | $5.76 | $5.64 | -2.1% |
| 2024-07-24 | $5.59 | $5.47 | -2.1% |
| 2024-04-24 | $5.48 | $5.20 | -5.1% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.12%
Growth (3Y)
14.13%
Growth (5Y)
10.76%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 23, 2026 | Mar 13, 2026 | $0.60 | 0.48% |
| Nov 17, 2025 | Dec 05, 2025 | $0.60 | 0.51% |
| Aug 11, 2025 | Aug 29, 2025 | $0.60 | 0.49% |
| May 29, 2025 | Jun 17, 2025 | $0.50 | 0.35% |
| Feb 24, 2025 | Mar 14, 2025 | $0.50 | 0.35% |
| Nov 18, 2024 | Dec 06, 2024 | $0.50 | 0.32% |
| Aug 12, 2024 | Aug 30, 2024 | $0.50 | 0.30% |
| May 30, 2024 | Jun 18, 2024 | $0.40 | 0.29% |
| Feb 23, 2024 | Mar 15, 2024 | $0.40 | 0.26% |
| Nov 10, 2023 | Dec 04, 2023 | $0.40 | 0.27% |
| Aug 11, 2023 | Sep 05, 2023 | $0.40 | 0.30% |
| May 24, 2023 | Jun 14, 2023 | $0.38 | 0.28% |
| Feb 24, 2023 | Mar 17, 2023 | $0.38 | 0.28% |
| Nov 10, 2022 | Dec 05, 2022 | $0.38 | 0.30% |
| Aug 12, 2022 | Sep 02, 2022 | $0.38 | 0.30% |
| May 25, 2022 | Jun 15, 2022 | $0.36 | 0.29% |
| Feb 25, 2022 | Mar 18, 2022 | $0.36 | 0.30% |
| Nov 12, 2021 | Dec 06, 2021 | $0.36 | 0.28% |
| Aug 13, 2021 | Sep 02, 2021 | $0.36 | 0.30% |
| May 26, 2021 | Jun 16, 2021 | $0.34 | 0.27% |
Key Takeaways
Revenue grew 4.28% annually over 5 years — modest growth
Earnings declined -12.17% over the past year
ROE of 25.28% indicates high profitability
Debt/Equity of 0.16 — conservative balance sheet
Generating 325.48M in free cash flow
Cash machine — converts 122.71% of earnings into free cash flow
Growth
Revenue Growth (5Y)
4.28%
Revenue (1Y)4.06%
Earnings (1Y)-12.17%
FCF Growth (3Y)9.10%
Quality
Return on Equity
25.28%
ROIC22.37%
Net Margin10.48%
Op. Margin13.37%
Safety
Debt / Equity
0.16
Current Ratio1.05
Interest Coverage193.28
Valuation
P/E Ratio
19.90
Forward P/E15.67
P/B Ratio5.39
EV/EBITDA15.84
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.06% | Revenue Growth (3Y) | 5.70% |
| Earnings Growth (1Y) | -12.17% | Earnings Growth (3Y) | -1.34% |
| Revenue Growth (5Y) | 4.28% | Earnings Growth (5Y) | -0.31% |
| Profitability | |||
| Revenue (TTM) | 2.53B | Net Income (TTM) | 265.24M |
| ROE | 25.28% | ROA | 16.17% |
| Gross Margin | 29.97% | Operating Margin | 13.37% |
| Net Margin | 10.48% | Free Cash Flow (TTM) | 325.48M |
| ROIC | 22.37% | FCF Growth (3Y) | 9.10% |
| Safety | |||
| Debt / Equity | 0.16 | Current Ratio | 1.05 |
| Interest Coverage | 193.28 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.12% |
| Dividend Growth (3Y) | 14.13% | Dividend Growth (5Y) | 10.76% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 19.90 | Forward P/E | 15.67 |
| P/B Ratio | 5.39 | P/S Ratio | 2.09 |
| PEG Ratio | -2.78 | Forward PEG | N/A |
| EV/EBITDA | 15.84 | Fwd EV/EBITDA | 10.94 |
| Forward P/S | 1.98 | Fwd Earnings Yield | 6.38% |
| FCF Yield | 6.17% | ||
| Market Cap | 5.28B | Enterprise Value | 5.36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.53B | 2.43B | 2.26B | 2.13B | 2.14B |
| Net Income | 265.24M | 302.00M | 272.51M | 249.62M | 268.55M |
| EPS (Diluted) | 18.42 | 19.89 | 17.93 | 16.53 | 16.85 |
| Gross Profit | 758.34M | 854.35M | 798.82M | 765.09M | 769.80M |
| Operating Income | 338.25M | 366.49M | 340.57M | 343.50M | 343.04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.64B | 1.67B | 1.67B | 1.44B | 1.34B |
| Total Liabilities | 660.61M | 549.58M | 560.22M | 643.30M | 719.45M |
| Shareholders' Equity | 979.41M | 1.12B | 1.11B | 798.72M | 623.27M |
| Total Debt | 154.76M | 140.84M | 155.11M | 247.01M | 323.54M |
| Cash & Equivalents | 74.52M | 178.35M | 263.96M | 74.13M | 32.90M |
| Current Assets | 302.62M | 394.75M | 500.84M | 272.61M | 230.29M |
| Current Liabilities | 287.13M | 285.70M | 312.05M | 297.21M | 302.40M |